Khavinson's Lingual Cytomaxes - bioregulators based on natural peptides in a sublingual form of application.
In early 2020 as part of expanding collaboration with the St. Petersburg Institute of Bioregulation, Gerontology and Peptides, we present an new product - monopeptides in sublingual form of application. The new line includes peptides of the Cytomax range (8 unique products) in sublingual monopeptides. When using the sublingual version, the daily dose is reduced twice in comparison with capsule Cytomax peptides. This is due to the new form of absorbtion of bioregulators which provides a higher bioavailability of the drug and the speed of its action.
Cytomaxes contain natural peptides, each of which has an effect on a specific organ or body part. Natural peptides are highly bioavailable and have a mild effect on the issue at hand, regulating the general condition of a person.